Effect of structural modifications on the biological properties of aminoglycoside antibiotics containing 2-deoxystreptamine.
D000123:Acetyltransferases / Q000378:metabolism; D000617:Aminoglycosides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004352:Drug Resistance, Microbial; D005601:Framycetin / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009355:Neomycin / Q000494:pharmacology; D009713:Nucleotidyltransferases / Q000378:metabolism; D010303:Paromomycin / Q000494:pharmacology; D010770:Phosphotransferases / Q000378:metabolism; D013307:Streptomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D013329:Structure-Activity Relationship
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D005601:Framycetin; D007612:Kanamycin; D010303:Paromomycin; D000123:Acetyltransferases; D010770:Phosphotransferases; D009713:Nucleotidyltransferases; D009355:Neomycin; D013307:Streptomycin